financetom
Business
financetom
/
Business
/
Merck's oral HIV treatment meets main goal in late-stage study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck's oral HIV treatment meets main goal in late-stage study
Nov 19, 2025 4:16 AM

Nov 19 (Reuters) - Merck ( MRK ) said on Wednesday that

its experimental oral HIV treatment met the main goal of a

late-stage trial.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved